AlphaOS

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

AKTX

Akari Therapeutics Plc

Healthcare · Pharmaceuticals

$9.81Sep 28, 2026

AI confidence 50% · refreshes every 15s during session

Investment Snapshot

Limited proprietary earnings coverage for AKTX yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 78d ago

AKTX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on AKTX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Akari Therapeutics Plc (AKTX) — events, not interpretation.

Event
Last session September 28, 2026 at $9.81.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Akari Therapeutics Plc (AKTX)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for Akari Therapeutics Plc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Pharmaceuticals
Market cap:
$1.53T
Revenue:
$0

AKTX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Akari Therapeutics Plc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Related

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.